Immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs.
Antonio CristaudoDario GraceffaF PimpinelliF SperatiG SpoletiniC BonifatiR PelliniV LoraM PontoneO Di BellaD BraccoA MorronePublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)